Delivery Order SPE2DB20D3103-SPE2DB25FP3T4
- Not listed
- This is a $1,460.47 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4568275407 - FEBUXOSTAT 40 MG TABLET 30S. The delivery order has an ultimate completion date of May 19, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,494.03 and an ultimate completion date of May 20, 2025. The award was made on May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,675.64 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Febuxostat 40 mg tablets, supplied in 30-count packages. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide range of pharmaceuticals and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The $2,437.82 firm fixed-price contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,639.36, is for the delivery of 30-count bottles of the medication febuxostat 40 mg tablets. The order has a completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $1,014.19, is for the supply of 4565560153 FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price pricing structure and an ultimate completion date of August 26, 2024. There is no set-aside designation on this contract. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,563,472,907 units of febuxostat 40 mg tablets, with a potential value of $1,659.19. The delivery order has a completion date of January 30, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken,...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The contract is for the supply of FEBUXOSTAT 40 MG TABLET 30S, a prescription medication, to support the healthcare needs of military treatment programs and facilities worldwide. The award has a firm fixed price of $1,025.31 and an ultimate completion date of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FEBUXOSTAT 80 MG TABLET 30S, a medication. The contract has a ceiling value of $3,298.49 and is a firm fixed price delivery order with a completion date of June 18, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP3T4Delivery Order
This is a $1,725.02 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FEBUXOSTAT 40 MG TABLET 30S, with a period of performance ending on July 3, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set-aside and represents open competition. Through this and other federal contracts, Amerisourcebergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/2/25 |